These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21962938)

  • 41. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report.
    Huang W; Ren X; Shen F; Xing B
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous valproate treatment: some observations.
    Duggal HS
    Can J Psychiatry; 2002 Feb; 47(1):96. PubMed ID: 11873717
    [No Abstract]   [Full Text] [Related]  

  • 45. Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies.
    Davanzo PA; McCracken JT
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):159-82. PubMed ID: 10674195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
    Davis LL; Bartolucci A; Petty F
    J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
    Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
    J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical standing of valproate treatment of bipolar disorders].
    Grunze H; Adli M; Bauer M; Berger M; Bergmann A; Bräunig P; Bschor T; Falkai P; Gastpar M; Greil W; Kasper S; Krüger S; Laux G; Müller WE; Naber D; Walden J
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):220-35. PubMed ID: 17427043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.
    Scott J; Pope M
    Am J Psychiatry; 2002 Nov; 159(11):1927-9. PubMed ID: 12411230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormonal effects of valproic acid?
    Garland EJ; Behr R
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1424-5. PubMed ID: 8936907
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetics of valproic acid in patients with bipolar disorder.
    Vasudev K; Das S; Goswami U; Tayal G
    J Psychopharmacol; 2001 Sep; 15(3):187-90. PubMed ID: 11565626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous valproate loading in acutely manic and depressed bipolar I patients.
    Grunze H; Erfurth A; Amann B; Giupponi G; Kammerer C; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):303-9. PubMed ID: 10440456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
    Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
    J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
    [No Abstract]   [Full Text] [Related]  

  • 55. Case of significantly delayed divalproex-induced thrombocytopaenia.
    Park A; Shapiro B; Hedayati B; Faziola L
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31796434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mood stabilizers in Asperger's syndrome.
    Duggal HS
    Aust N Z J Psychiatry; 2001 Jun; 35(3):390-1. PubMed ID: 11437822
    [No Abstract]   [Full Text] [Related]  

  • 57. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
    Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M
    Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risperidone, a risk factor for valproate-induced encephalopathy?
    Rodrigues-Silva N; Venâncio Â; Bouça J
    Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous valproate treatment of severe manic symptoms after gastric bypass surgery: a case report.
    Kaltsounis J; De Leon OA
    Psychosomatics; 2000; 41(5):454-6. PubMed ID: 11015641
    [No Abstract]   [Full Text] [Related]  

  • 60. Fulminant hepatic failure in the context of reinstituting valproate use.
    Rej S; Chen T; Edwards M; Zicherman V
    Psychosomatics; 2014; 55(3):303-4. PubMed ID: 24360531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.